Monument Capital Management bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 14,974 shares of the real estate investment trust's stock, valued at approximately $276,000.
Several other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC acquired a new position in shares of Sabra Healthcare REIT during the 1st quarter worth approximately $298,000. New York State Teachers Retirement System increased its position in shares of Sabra Healthcare REIT by 12.1% during the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock worth $5,619,000 after purchasing an additional 34,591 shares during the last quarter. M&T Bank Corp increased its position in shares of Sabra Healthcare REIT by 2.1% during the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock worth $905,000 after purchasing an additional 1,059 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Sabra Healthcare REIT by 4.7% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock worth $331,000 after purchasing an additional 853 shares during the last quarter. Finally, Ethos Financial Group LLC acquired a new position in shares of Sabra Healthcare REIT during the 1st quarter worth approximately $1,150,000. Institutional investors own 99.40% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on SBRA shares. Cantor Fitzgerald started coverage on Sabra Healthcare REIT in a research report on Wednesday, October 1st. They set a "neutral" rating and a $20.00 price target on the stock. Scotiabank boosted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. Truist Financial boosted their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a research report on Tuesday, September 2nd. BMO Capital Markets boosted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a report on Monday, August 25th. Finally, Wells Fargo & Company boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.71.
Get Our Latest Stock Report on SBRA
Sabra Healthcare REIT Stock Down 0.8%
SBRA stock opened at $17.74 on Friday. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $4.25 billion, a PE ratio of 23.34, a PEG ratio of 1.20 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The business's 50 day simple moving average is $18.76 and its 200 day simple moving average is $18.17.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The business had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm's quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were paid a $0.30 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.8%. Sabra Healthcare REIT's payout ratio is 157.89%.
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Recommended Stories
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.